Clinical Trial Update: Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing daily versus twice-weekly dosing of chidamide and evaluating differences in therapeutic effect, pharmacokinetics/pharmacodynamics, and E…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection
• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Huiqiang Huang | Conditions: Lymphoma, Extranodal NK-T-Cell, EBV | Phase 2 | Status: UNKNOWN